| 注册
首页|期刊导航|中国临床药理学与治疗学|脂氧素A4抑制缺氧诱导的滋养细胞氧化应激和凋亡

脂氧素A4抑制缺氧诱导的滋养细胞氧化应激和凋亡

黄艳君 吴洁 蒋维 王晓 黄引平

中国临床药理学与治疗学2017,Vol.22Issue(4):361-366,6.
中国临床药理学与治疗学2017,Vol.22Issue(4):361-366,6.

脂氧素A4抑制缺氧诱导的滋养细胞氧化应激和凋亡

Lipoxin A4 attenuates hypoxia induced oxidative stress and apoptosis in human first trimester trophoblast cells

黄艳君 1吴洁 1蒋维 1王晓 1黄引平1

作者信息

  • 1. 温州医科大学附属第一医院产科,温州325000,浙江
  • 折叠

摘要

Abstract

AIM:To investigate the effect of lipoxin A4 (LXA4) on oxidative stress and apoptosis of human first trophoblast cells induced by hypoxia.METHODS:Primary human trophoblast cells were randomized into normoxia group,hypoxia group and hypoxia + LXA4 (1,10 and 100 nmol/L) groups.The level of ROS was determined by DCFH-DA,the activity of SOD,CAT and GPx were detected by the corresponding kits.The apoptosis rate was analyzed by flow cytometer method and the level of Bcl-2 and Bax protein were observed by Western Blot.RESULTS:Compared with normoxia group,the level of ROS and apoptosis rate increased (P < 0.05) while the activity of SOD,CAT and GPx decreased (P <0.05) in hypoxia group.Compared with hypoxia group,the level of ROS and apoptosis rate decreased (P < 0.05),while the activity of SOD,CAT and GPx increased (P < 0.05) in hypoxia + LXA4 (1,10and 100 nmol/L) groups.Compared with normoxia group,the level of Bcl-2 protein in hypoxia group decreased and the level of Bax protein increased (P < 0.05).Compared with hypoxia group,the level of Bcl-2 protein in hypoxia + LXA4 (1,10 and 100 nmol/L) groups increased and the level of Bax protein decreased (P < 0.05).CONCLUSION:Lipoxin A4 attenuates hypoxia induced oxidative stress and apoptosis in human first trophoblast cells.The regulation of Bcl-2/Bax expression may be an important mechanism of LXA4 in inhibiting apoptosis.

关键词

脂氧素/滋养细胞/缺氧/氧化应激/凋亡

Key words

lipoxin/trophoblast/hypoxia/oxidative stress/apoptosis

分类

医药卫生

引用本文复制引用

黄艳君,吴洁,蒋维,王晓,黄引平..脂氧素A4抑制缺氧诱导的滋养细胞氧化应激和凋亡[J].中国临床药理学与治疗学,2017,22(4):361-366,6.

基金项目

国家自然科学基金项目(81070510、81671480) (81070510、81671480)

浙江省自然科学基金项目(Y2101233、LY16H040009) (Y2101233、LY16H040009)

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量1
|
下载量0
段落导航相关论文